Overview

The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery

Status:
Recruiting
Trial end date:
2027-09-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to determine a difference in participant reported pain after endometriosis surgery in participants given oral metronidazole versus placebo.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
University of Louisville
Treatments:
Metronidazole
Criteria
Inclusion Criteria:

- Able to give informed consent

- Women aged 18-50 years old

- Scheduled to undergo excision of endometriosis

- Able to read and write in English and or Spanish

- Pain score > 2 on a 10 point visual analogue scale at baseline

- Negative screening by CAGE questionnaire

Exclusion Criteria:

- Refusal to surgery

- Contraindication to surgery

- Known allergy to metronidazole

- Known allergy to any component in gelatin placebo capsules

- Scheduled hysterectomy

- Endometriosis excision surgery within the last 3 months

- Elevated serum creatinine

- Abnormal liver function test greater than 2 times the normal

- Current pregnancy

- Breastfeeding

- Use of Disulfiram within the last 2 weeks

- History of Cockayne syndrome

- Inability to abstain from alcohol during the use of study drug